SAN DIEGO, July 21, 2011 /PRNewswire/ -- HUYA Bioscience International, a leader in globalizing China's biopharmaceutical innovations, today announced a strategic partnership with the Zhongshan National Health Technology Park. The alliance will unite the strength and resources of both parties to accelerate the development of China's pharmaceutical discoveries.
HUYA is one of the first companies to have recognized China's potential to help meet the global need for new preclinical and clinical stage compounds. The company is committed to facilitating and promoting the global development and commercialization of novel pharmaceutical products originating in China. HUYA has established a series of collaborations with leading universities and research institutions throughout China and has pioneered in-licensing clinical stage compounds from the country, utilizing its expertise to advance these compounds for global markets.
Zhongshan National Health Technology Park, jointly established by the Ministry of Science and Technology, Guangdong Provincial Government and Zhongshan Municipal Government, is the first nationally designated health industrial park in China that has been built in compliance with the international standards of GLP, GMP and GCP, which qualifies the development, clinical experiments and production of new medicines. Situated at the Torch Hi-tech Industrial Development Zone in Zhongshan, Guangdong, the park has attracted numerous national and international enterprises and has formed co-operational relationships with renowned universities worldwide.
Under the agreement, Zhongshan National Health Technology Park and HUYA will collaborate to promote new drug development. HUYA may attend project promotion events and actively participate in the annual Health and Development Zhongshan Forums at the park, or organize HUYA's partners to participate in the events. HUYA may also recommend its global pharmaceutical partners to collaborate with the park.
HUYA will have the first opportunity to provide assistance in evaluating R&D projects conducted by pharmaceutical enterprises residing in the park. HUYA will be able to internationalize select programs through HUYA's innovative co-development model and the company's worldwide pharmaceutical partners, thereby introducing qualified projects from companies in the park into global markets.
"This exciting partnership between HUYA and Zhongshan National Health Technology Park will support innovation and growth of China's pharmaceutical industry," said Clement Gingras, HUYA's CTO and COO, China. "HUYA and Zhongshan National Health Technology Park share the goal of improving the health and lives of people by providing innovative pharmaceutical products."
Conghong Yu, Director of Zhongshan Health Technology Park, commented, "With HUYA's expertise in developing innovative products in accordance with international standards, this alliance will certainly aid the park's endeavor to become a nationally and internationally known health technology industrial base."
ABOUT HUYA BIOSCIENCE INTERNATIONAL
HUYA is the leader in global pharmaceutical co-development with Chinese partners. With seven offices strategically located in China, the most comprehensive Chinese compound portfolio, and a rapidly growing number of exclusive agreements with premier Chinese research and development organizations, HUYA is uniquely positioned to identify and license novel Chinese compounds. HUYA offers Western pharmaceutical companies efficient access to innovative therapeutic opportunities and helps to reduce deal-making complexity in China. The company has become a champion of guiding China's biomedical innovations to the worldwide marketplace. HUYA has joint headquarter offices in San Diego, CA, USA and Shanghai, China. Additional information about the company is available at www.huyabio.com.
ABOUT ZHONGSHAN NATIONAL HEALTH TECHNOLOGY PARK
Zhongshan National Health Technology Park is situated in the Torch Hi-tech Industrial Development Zone in Zhongshan, Guangdong province and covers a land area of 13.5 square km. It is the first established national-level health technology industrial base in China. The park has gathered a large number of national and worldwide companies which are engaged in the industrial fields of Chinese herbal and western synthetic medicines, healthcare products, biological engineering, health foods, medical apparatus, cosmetics and pharmaceutical packaging materials. Its total industrial output value in 2010 amounted to more than US $2.7 billion. Zhongshan National Health Technology Park has set up its future development strategy, it will continue to grow and implement its Greater Health industrial concept to develop the business in the direction of internationalization and standardization in accordance to international practice. For more information, please visit www.zstorch.gov.cn.
Yung-Chih Wang, Ph.D., MBA
Vice President, Corporate Development, China
HUYA Bioscience International
Qing (Vicky) Xia, MS, MBA
Senior Business Development Manager
HUYA Bioscience International
SOURCE HUYA Bioscience International